Introduction
The organisms that cause psittacosis were isolated from affected humans and psittacine birds during the psittacosis pandemic of 1929-30,1 and the agent of lymphogranuloma venereum was isolated at about the same time. This was followed by a gradual realisation that chlamydial infections were widespread in other birds and mammals. In 1957, the isolation of the aetiological agent of trachoma in chick embryos was reported.2 Soon after, the organisms responsible for inclusion blennorrhoea of the newborn and for infection of the genital tract of the parents were recovered,3 and identical organisms were found in the genital tract of men presenting with non-gonococcal urethritis. 4 Because the organisms from the eye and genital tract could not easily be distinguished, and because the eye disease associated with them formed a continuous spectrum ranging in severity from inclusion conjunctivitis to trachoma, the expression 'TRIC agents' was used for these organisms (TR for trachoma, IC for inclusion conjunctivitis). The TRIC agents belong to the larger group of organisms that has been called the PLT (psittacosis-lymphogranuloma-trachoma) group of agents or an array of other terms including Bedsonia. This term was used to recognise the isolation and characterisation of the agent of psittacosis by Sir Samuel Bedson. However, for taxonomic reasons, it has been superseded by the generic name Chlamydia (Greek, chlamys: a cloak draped from the shoulder, meant to describe the draping of the intracytoplasmic inclusions around the nucleus of the host cell). The genus is in the family chlamydiaceae, of the order Chlamydiales5 and within the genus two species are recognised: Chlamydia psittaci and Chlamydia trachomatis. 6 Recently, Wright7 has said that it is wrong to refer to organisms of the genus Chlamydia as chlamydiae since chlamydia is already a plural Greek word (singular = chlamydion). However, according to the definitive Received for publication 26 September 1979 rules of taxonomy, generic names of bacteria are regarded as 'Latin' words. Chlamydia is thus to be used as a singular, feminine noun, and its Latinised plural becomes chlamydiae. We have therefore used the word 'chlamydiae' in the past and henceforth shall continue to do so.
This review is not concerned with psittacosis or trachoma although they are mentioned where it is pertinent to do so. The discussion is concerned with strains of C. trachomatis found in the genital tract, the evidence that is available to show that they are a cause of certain diseases, the proportion of disease they cause, and possible mechanisms underlying disease production. In addition, laboratory diagnosis, the value of serology, and the outlook for a vaccine are considered.
Characteristics of chlamydiae Some of the properties of chlamydiae, compared with those of mycoplasmas, bacteria, and viruses, are presented in Table 1 . In particular, chlamydiae (i) do not stain with the Gram stain, (ii) contain DNA and RNA, (iii) are susceptible to certain antibiotics, (iv) have a rigid cell wall similar in structure and content to that of the Gram-negative bacteria, and (v) multiply by binary fission. In these various respects they are bacteria-like; they may, in fact, be regarded as bacteria that have adapted to an intracellular environment, being (vi) obligate intracellular parasites. In this latter feature, chlamydiae are different from mycoplasmas and bacteria but similar to viruses, needing viable cells for their multiplication and survival, as described below.
CHLAMYDIAL GROWTH CYCLE (Fig. 1 ) Despite the occurrence of binary fission as in bacteria, chlamydiae have a complicated growth cycle8 involving both an extracellular and intracellular existence. The infectious particle or elementary body is about 300 nm in size, is metabolically inactive, and has a resistant, rigid envelope. The role of Chlamydia trachomatis in genital-tract and associated diseases 45 Although the original micro-IF method was complicated, involving the application of spots of numerous egg-grown antigens to slides with mapping pens, it was found to have advantages over the CF test. Thus, it allowed several serum dilutions to be tested on one slide against a number of antigens, the detection of type-specific antibody, and, as it was an indirect test, different immunoglobulin classes to be detected by the use of different antisera. Above all the test was very sensitive.
Sensitivity The results of studies in which antigens comprising either single or multiple serotypes have been used, show that about 80% of men and over 90% of women with chlamydial genital-tract infections have antibody (see later section). Geometric mean (GM) titres of antibody in men are not high, probably because the antigenic stimulus to antibody production by chlamydiae localised superficially in the urethra is minimal; titres are higher in women, and considerably higher in patients with LGV and in some with sexually acquired reactive arthritis.
Specificity In an early study,45 antibody was found in the sera of 94% of patients with known chlamydial infections and 79% of these had a typespecific response. However, the results obtained from more widespread use of the micro-IF test suggest that both type-specific and broadly crossreacting group-specific antibodies are being detected.36 46 Although the micro-IF test is sensitive, the 'non-specific' reactivity associated with it remains a problem. Thus, 23 %-40% of 'normal' adults have been found to have antibody,'252 while 10%o-76% of men with chlamydia-negative NGU and 30%-50% of chlamydia-negative women in a 'venereal disease population' have been found seropositive (see later section). This apparent lack of specificity may be due to failure to isolate chlamydiae efficiently, to antibody remaining from a previous infection, or to non-specific cross-reactivity with antibody against an unrelated microorganism.
Despite the undisputed value of the micro-IF test in seroepidemiology, the problems of specificity raise serious doubts about its use as a diagnostic tool for individual patients with chlamydial infections. This will be discussed further in a later section.
The role of Chlamydia trachomatis in genital-tract and associated diseases The evidence that strains of C. trachomatis are a cause of certain genital-tract diseases is presented below (see also Table 10 ).
NON-GONOCOCCAL URETHRITIS

Isolation studies
Chlamydiae have been isolated from 25Y%-58% of men with NGU but from only 0 %-7% of those without disease (Table 5) .
Antibiotic studies Antibiotics such as sulphafurazole (sulfasoxizole), which inhibit chlamydiae but not ureaplasmas in vitro, are effective in treating chlamydia-positive, ureaplasma-negative cases.75 In addition, patients from whom only chlamydiae have been isolated respond significantly better to tetracycline therapy than patients who are given a placebo.63 Antibiotic studies Antibiotics such as ampicillin, which inhibit Neisseria gonorrhoeae but are not so effective against chlamydiae in vitro, do not prevent the development of PGU, whereas antibiotics which inhibit the multiplication of both these microorganisms do prevent its development.58 86 90 91 Taylor-Robinson and Thomas
The role of Chlamydia trachomatis in genital-tract and associated diseases Serological studies Holmes and colleagues52 used the micro-IF technique to look for additional evidence of chlamydial infection in PGU with little success because they found serological evidence of recent infection in only one additional chlamydia-negative patient. In two studies,86 87 IgG antibody to C. trachomatis was found in 100% and 48%, respectively, of men with chlamydia-positive PGU, and in 45% and 25% of men with chlamydia-negative PGU. In the second study, rises in titre of IgG antibody were sought but not found although IgM was detected in 8 of 11 (73%) chlamydia-positive men who also had IgG, but in only 1 of 6 (17%) chlamydia-negative men.
Apart from confirming the presence of chlamydial infection in some men with PGU, none of these results by itself is helpful in indicating a causative r6le for the organisms. The evidence for this is best provided by the isolation and antibiotic-orientated studies.
PROSTATITIS Surprisingly, there are no reports of studies concerned with the role of C. trachomatis in acute prostatitis, although the prostate must be involved in some cases of NGU. However, MArdh and colleagues92 investigated the possible role of C. trachomatis in non-acute (chronic) prostatitis. They studied 53 men but isolated chlamydiae from the urethra of only one, and from none of 28 specimens of prostatitic fluid. Only 4 of the 50 men studied serologically by the micro-IF technique had IgM antibody at a titre of 1:8 or greater and, therefore, evidence of a current or recent infection. Examination of prostatic fluid was no more informative. The authors concluded that C. trachomatis appears to play a minor aetiological role, if any, in non-acute prostatitis. We doubt, however, whether this evidence is conclusive since it seems feasible that chlamydiae could infect initially and trigger the development of chronic disease and yet not be detectable subsequently. REITER S SYNDROME
The major problems in attempting to associate chlamydiae with this syndrome and the investigative approaches which are likely to overcome these problems and provide the most useful information have been discussed recently.96
Isolation studies Since chlamydiae have been isolated in most studies from no more than 50% of patients with NGU and since only a few NGU patients develop sexually acquired reactive arthritis (SARA) or Reiter's syndrome (urethritis, arthritis, and conjunctivitis), it would be feasible for all patients with SARA or Reiter's syndrome to be chlamydiaisolate negative. Recovery of chlamydiae from the urethra was infrequent in much of the early work in which isolation was attempted in the yolk sac of embryonated hens' eggs97 and even later when cell cultures were used.98 99 It seems that this was due largely to patients having been treated with antibiotics before specimens could be taken. 
CERVICITIS
Isolation studies Jones and colleagues3 were the first to isolate C. trachomatis from the cervix of a woman who had given birth to a baby with inclusion blennorrhoea. Subsequently, it has been shown by numerous workers, for example, Paavonen and colleagues,72 that chlamydiae are recovered from the cervix of a much greater proportion of women who are partners of men with chiamydia-positive NGU than of those who are partners of men with chlamydia-negative NGU. This association is represented in Figure 4 . In addition, there have been numerous studies (Table 8) , the results of which show that C. trachomatis is recovered from cervical specimens of a greater proportion of women attending venereology clinics than of those attending other types of clinics. There is obviously no problem in isolating chlamydiae from cervical specimens of about one-quarter of women attending venereal disease clinics, but there is in deciding whether the organisms produce cervical disease. A major difficulty is that several potentially pathogenic microorganisms can usually be isolated from cervical specimens taken from women attending clinics. 106 salpingitis had such an antibody titre (GM titre of 1:21) and only 10-5% of those without salpingitis (GM titre of 1:2). Furthermore, there was a correlation between the degree of tubal and/or pelvic inflammation and the GM titre of IgM antibody. Fluids from the pouch of Douglas of 27 women with acute salpingitis had high GM titres of chlamydial IgG and IgM antibody, and again the GM titres of both classes correlated with the degree of tubal and/or pelvic inflammation.
Paavonen and colleagues8 detected a fourfold or greater rise in the titre of antibody to C. trachomatis measured by immunofluorescence in 10 (46 %) of 22 women with symptoms of acute salpingitis from whom chlamydiae were isolated from the cervix and in 7 (14%) of 50 women with symptoms who were chlamydia-culture negative.
Ripa'34 and Treharne and colleagues135 consider that a C. trachomatis serum IgG antibody titre of 1 :64 or greater in a patient who has clinical signs of acute salpingitis may be taken as evidence of the disease being caused by chlamydiae, and on this basis they believe that two-thirds of all cases have a chlamydial aetiology. Certainly, such a single antibody titre cannot be regarded as diagnostic in an individual case. Furthermore, since a chlamydial antibody titre of 1:64 or greater is seen in disease of the lower genital tract, it would seem to us that the use of this figure to determine the extent of salpingitis due to C. trachomatis epidemiologically might provide an inaccurate assessment.
Animal studies Ripa and colleagues136 inoculated C. trachomatis organisms obtained from the fallopian tubes of patients with acute salpingitis directly into the oviducts of two grivet monkeys and through the cervical canal into the uterine cavity of another monkey. A self-limited acute salpingitis occurred in the three animals, chlamydiae being recovered up to three weeks after inoculation. At laparotomy a watery exudate was seen in the abdominal ostia of the tubes and they were swollen and reddened with an infiltrate, mainly lymphocytic, in the mucosal, muscular, and subserosal layers. In addition, there was a serological response with an IgM to IgG antibody conversion. This fulfilment of Koch's postulates adds to the earlier evidence that C. trachomatis is capable of causing acute salpingitis in humans.
ABORTION AND INFERTILITY
Chlamydial genital infection is one cause of abortion in various animal species137 so it is reasonable to consider whether C. trachomatis might be responsible for some cases of spontaneous human abortion. In this regard, Giroud and Dumas138 noted a correlation 218 between high titres of chlamydial CF antibody and the incidence of early spontaneous abortion. In addition, Schachter139 reported the isolation of chlamydiae from the aborted products of conception, but these observations do not seem to have been followed up so far by others.
The fertility of a couple depends on the sum of the fertility of each partner. In men, it is possible that acute urethroprostatitis and epididymitis could lead to chronic disease and subsequent infertility; the r'le of chlamydiae in causing these conditions has been discussed. In women, the possibilities for chlamydial involvement are with the same syndrome were 3 to 11 weeks of age. Respiratory findings were usually dominated by tachypnoea and a distinctive cough. In severe cases, this was pertussis-like in tonal quality but differed from it in being a series of staccato coughs, each separated by a brief inspiration, without an inspiratory whoop. The course was protracted, cough and tachypnoea sometimes taking weeks to clear and radiographic changes persisting even longer. Chlamydiae were isolated from the nasopharynx of 18 of 20 infants with pneumonia. Oddly, IgG chlamydial antibody titres in their sera were much higher than those recorded in other chlamydial infections by any other group of workers. Nevertheless, the titres were significantly higher than those in the sera of infants with conjunctivitis alone, and this would be in accord with chlamydial involvement of a larger area of mucous membrane in the lung than in the eye. This finding, together with isolation of chlamydiae from a defined clinical syndrome, suggests that the organisms are one of the causes of infant pneumonia. However, caution needs to be exercised in making the diagnosis. The observation by Beem and Saxon142 that half of their 20 infants with pneumonia had conjunctivitis, as judged by history or examination, brings into focus the problem of knowing whether chlamydiae isolated from sputum or throat swabs are more than 'contaminants' from infected conjunctival secretions. This may be impossible in the absence of a distinctive clinical picture and suggestive serological data.148 149 Observations by other workers are needed and, indeed, are being made,150 but obviously they must not believe that isolation from the throat necessarily means that the organisms are the cause of the It may be that they were transmitted gastrointestinally from the conjunctivae or respiratory tract to the lower intestinal tract before sufficient gastric acid had been produced to kill them. This and the possibility that chlamydiae may cause gastrointestinal disease in infants need further investigation.
Genital strains of C. trachomatis have been isolated from the oropharynx of adults162 163 but it is debatable whether they cause pharyngitis.164 It is unlikely that they are able to negotiate passage through the adult stomach without being killed so that infection of the rectum of adults120 165 A subjective appraisal of the evidence that chlamydiae cause the various diseases previously mentioned is shown in Table 10 . This, in effect, is a summary of the previous sections. If chlamydiae are a cause of a particular disease, the question of what proportion of cases is attributable to chlamydiae then arises. On a world-wide basis, the extent to which C. trachomatis causes genital-tract and associated disease is difficult to assess because, as shown in Tables 5 and 8 , reports of successful attempts to isolate chlamydiae have come entirely from developed countries. Furthermore, in any particular country, the prevalence of chlamydial infection in one geographical location may differ greatly from the prevalence in another. The extent to which chlamydiae might be the cause of each disease which we have considered has been discussed to some extent previously and is presented in Table 10 . The problem of making this analysis is seen when an attempt is made to estimate, for example, the prevalence of chlamydial infection in neonatal conjunctivitis and pneumonia. Prentice and colleagues'70 did not isolate chlamydiae from 104 consecutive cases of neonatal conjunctivitis whereas Rees and colleagues130 recorded an isolation rate of 3200 in a selected series of cases in a different part of the United Kingdom. Alexander and co-workers'46 in the USA found that 12-7% of 142 unselected pregnant women had chlamydial infection of the cervix, and conjunctivitis developed in 9 (50%) of 18 infants born to these women. Schachter'71 reported that only 50 of the pregnant women studied by his group had chlamydial infection of the cervix but the conjunctivitis attack rate was similar, 10 of 25 infants at risk acquiring laboratoryproven disease. Thus, based on these figures from the USA, if the cervical carrier rate is 5Y%-13 %, 2 %-6 % of all newborn infants will develop inclusion conjunctivitis. We suspect that this is an overestimate of the disease throughout the world and it does not, of course, give any indication of the proportion of neonatal conjunctivitis cases that are due to chlamydiae.
Pneumonia in infants, caused by chlamydiae, must occur as a result of transmission of the organisms directly from the maternal genital tract, or indirectly via infectious conjunctival secretions. It seems reasonable to suppose, therefore, that a knowledge of the frequency of neonatal chlamydial conjunctivitis might provide some clue to the frequency of chlamydia-induced pneumonia. Obviously, since the lung is less exposed to infection than the eye, it seems likely that the incidence of 220 Table 10 can be only an estimate. Furthermore, two other factors make an accurate assessment impossible. These may be presented as follows: (i) because chlamydiae have been isolated not only from women but also from men who are not suffering from symptoms, the isolation of chlamydiae from a patient with disease does not mean that the organisms unquestionably cause the disease, although this is usually the case; (ii) it is possible that the genital-tract disease of patients from whom chlamydiae cannot be isolated is, in fact, chlamydial in origin. Thus, it is possible that in a patient who has experienced one or more episodes of chlamydial infection, chlamydiae could stimulate disease but be eliminated before the opportunity to isolate them arises and so give the illusion of non-chlamydial disease.
Mechanisms underlying the pathogenicity of chlamydiae ADHERENCE TO CELLS Cell attachment is necessary for both the pathogenicity and survival of chlamydiae, being the first step in the intracellular part of the growth cycle. Projections have been observed on the surface of C. psittaci organisms,'73 but whether they are concerned in attachment to cells or in phagocytosis is unknown. However, ingestion of chlamydial organisms involves heat-sensitive binding sites on their surfaces, and trypsin-sensitive host cell receptors for C. psittaci'74 and sialic acid receptors for C. trachomatis.175 Attachment and infection are also dependent on cell surface properties which can be modulated in vitro by growth of cells in different sera176 and by centrifugation.177 An understanding of the mechanisms involved in the binding of chlamydiae with cell surfaces in vitro may be helpful in designing more effective isolation procedures, but it is difficult to see how centrifugation-induced cellsurface changes are relevant to the pathogenicity of chlamydiae in naturally occurring infections.
TOXIC FACTORS
Large numbers of C. psittaci organisms kill mice faster than can be accounted for by multiplication of the organisms.178 In addition, large numbers of these and C. trachomatis organisms, living or ultra-violet light-inactivated, rapidly kill cell cultures.179 This phenomenon, described as 'immediate toxicity', is apparently not due to either exotoxin or endotoxin activity as seen with various bacteria. It has been suggested that it is due to the formation of a lesion in the host cell membrane each time it ingests a chlamydial organism and that the rapidity of cell death is related to an increasing number of lesions. Whether this mechanism operates under more natural conditions where smaller numbers of organisms are likely to be found is dubious; smaller numbers of organisms need to multiply for death of the cell to occur.
IMMUNOLOGICAL FACTORS
It is obvious that chlamydiae can cause cell death but dead epithelial cells do not constitute all the pathological changes that are attributable to chlamydial infection. This point is emphasised by the fact that infection of human and bovine oviduct organ cultures by C. psittaci or C. trachomatis organisms causes minor histopathological changes and negligible functional damage180 and yet chlamydial infection in women is regarded as a cause of acute salpingitis. Organ cultures do not, of course, incorporate the immunological mechanisms of the host so that by inference it seems likely that such mechanisms play an important part in the disease process.
Whether sensitisation of the immune systems of the host by previous infection is an important factor in chlamydia-induced genital-tract disease is obviously a relevant consideration. Indeed, the question arises whether primary contact with chlamydiae causes disease or whether it occurs only secondarily to a previous clinically inapparent infection. The problem is that it is particularly difficult to determine whether a patient allegedly suffering from a primary genital infection has been infected previously. The question often arises whether there is a need to have a laboratory service for isolating chlamydiae from patients with genital infections. '82 In the case of men suffering from NGU, it seems to us that the usefulness of the result would not justify the laboratory effort required, since establishing whether chlamydiae were present or not would not alter the patient's treatment. Most laboratories will provide the results of culture attempts after patients have been treated, although by using a rapid isolation technique and by rearranging clinic routines, it is possible to have culture results before treatment starts.32 Even so, at the moment, knowledge of the culture results will not influence treatment. If chlamydiae develop resistance to tetracyclines, we can forsee that there will be greater need to isolate and perform antibiotic sensitivity tests for the management of patients. A proposal to have a chlamydial culture service for women'82 seems sensible, at least for some. In the case of contacts of men with NGU, since men with chlamydia isolatenegative disease respond to tetracycline therapy, it does not appear logical to treat with tetracyclines only those women who are found to harbour chlamydiae. If this is so, a specific chlamydial diagnosis seems unnecessary. However, many women attend clinics for other reasons, and it is apparent that some who are chlamydia-positive would undoubtedly go untreated if facilities for culture were not available.182 In addition, because not all neonatal conjunctivitis is chlamydial, it is helpful to know which cases are chlamydia-positive so that those needing treatment receive it and unnecessary broad-spectrum antibiotic therapy is avoided. Of course, chlamydial detection methods are an integral part of any programme concerned with an understanding of the aetiology, pathogenesis, and, indeed, epidemiology of genital infections. We must emphasise, however, that it is necessary to think in terms of 'cost-effectiveness' or 'cost-usefulness', and we do not believe that at the present time the usefulness of a routine chlamydial isolation service for all patients with genital infections justifies the cost of undertaking it. and 77 % of all the NGU patients, either chlamydiapositive or chlamydia-negative, in the studies shown in Table 6 had IgG antibody. In the absence of isolation studies, these findings mean only that these men had been exposed sometime in the past to chlamydiae.
In comparison with antibody titres in single serum samples, rising titres of IgG antibody and IgM antibody levels ( 77 181 In patients with active paratrachoma, or 'trachoma of genital transmission',183 antibody in tears has been shown to be similarly associated with active disease.
Genital-tract secretions In view of the observations above, it is plausible that antibody in genital-tract secretions might be an indicator of chlamydial genital disease. In this regard, the observations of Treharne and colleagues184 are interesting. They detected IgG and IgA antibodies to C. trachomatis in cervical secretions of women with non-specific genital infection and suggested that cervical antibody of either class at a titre of 1:8 or greater is closely associated with isolation of chlamydiae and that its detection may be used diagnostically. Forty-one percent of 272 women were regarded as chlamydia-positive on the basis of isolation, serum IgM, serum IgG antibody at a titre of 1:64 or greater, or cervical secretion IgA or IgG. However, since cervical antibody was found in only 27 of 35 women from whom chlamydiae were isolated, we must conclude that the value of detecting this antibody in diagnosis remains equivocal, at least until better evidence of its correlation with disease is available. Results of such studies in women are awaited with interest.
In men with NGU, Ng and colleagues'85 found local chlamydial antibody in 64% of men from whom chlamydiae were isolated and in 17 % of those whose discharge did not yield chlamydiae. To what extent the presence of the antibody can be specifically associated with current disease needs studying. It will also be worth determining whether local antibody can be correlated with recent or current infection in chlamydia culture-negative NGU as a means of assessing whether such cases are in any way associated with chlamydiae.
Other secretions Treharne and colleagues '35 examined fluids aspirated from the pouch of Douglas of six women with acute salpingitis. High titres of IgG and IgA antibodies were found in half of them, but apart from one case where the antibody titres in the pelvic fluid were greater than in the serum, the titres in the fluids reflected those in the sera. In these circumstances, examination of pelvic fluid seems to Observations on animals Guinea-pigs infected in the eye with the guinea-pig inclusion conjunctivitis agent have often been used as a model for the study of human trachoma, although the disease lacks the chronicity of the human disease. The model has, however, some relevance to the study of human chlamydial oculogenital infections because intraurethral inoculation of male animals results in an infection which may be transmitted to the genital tract of the female, and thence to the eye of the offspring.186 Male animals so infected become completely resistant to reinfection of the urethra but are still susceptible to infection of the eye four to six weeks later. 187 Vaginal infection also provides immunity of a similar kind.'88 189 Infection of the eye, however, results in resistance not only to ocular but also to genital infection six weeks later. These observations suggest that immunity is not dependent entirely upon a local phenomenon, although the presence of serum antibody does not bear a significant relationship to immunity,188 nor does passively transferred serum antibody confer immunity on a recipient.
Observations on man Although individuals may experience multiple attacks of NGU, there is a dearth of information on whether successive episodes are chlamydial in origin. Our own experience from observations over several years is that chlamydial urethritis may be followed by further episodes of disease from which chlamydiae cannot be isolated. If we presume that some of the subsequent episodes are due to chlamydiae, it is not known whether they occur as a result of infection with the same chlamydial serotype, immunity having waned, or whether they occur only with other serotypes to which there is no immunity. A second infection with a different serotype from the first has been recognised by detecting specific IgM antibody to the second serotype in the presence of IgG antibody to the first one.45 Such observations are, however, sparse, and clearly there is a lack of basic information about immunity produced by chlamydial infection of the human genital tract.
WHAT IS THE EVIDENCE THAT VACCINATION PROTECTS AGAINST DISEASE?
Observations on animals Early experiments on vaccination of monkeys were encouraging. Protection against ocular disease or a diminution in the severity of disease after challenge with live organisms was attained in monkeys by use of formolised vaccines,190 and in baboons by subcutaneous and intravenous inoculation of live trachoma elementary bodies.'9' However, challenge with a more virulent strain caused disease and, furthermore, Grayston and colleagues'92 noted that monkeys which became infected despite immunisation suffered more severe disease than unimmunised animals as a result of a hypersensitivity reaction. Several factors were found to be vital in producing immunity in monkeys.'93194 Vaccines containing at least 109 purified, inactivated elementary bodies per millilitre were necessary to provide protection, lower doses resulting in more severe disease; vaccination protected only against challenge with the same serotype, and multivalent vaccines were less effective because they contained fewer organisms of each serotype; mineral oil-emulsified vaccines were found to be most protective.
Another approach to immunisation was the topical instillation of killed, purified chlamydiae whichcause trachoma into the conjunctival sac ofowl monkeys. This resulted in a smaller number of conjunctival inclusions after challenge than in control animals and an increase in antibody titres in serum and eye secretions, antibody in both appearing to contribute to protection.'95 However, local antibody appears to be the more important in this regard because, in another study, immunity was found not to be related to serum antibody levels and no protection against challenge with infectious homologous trachoma organisms was conferred on owl monkeys by passively transferring to them sera containing specific antibodies. '96 The guinea-pig model has also been explored for testing the effectiveness of vaccines. Formalin-killed preparations of the guinea-pig inclusion conjunctivitis agent given intraperitoneally and intramuscularly as single doses or with booster inoculations failed to produce any significant immunity to subsequent challenge with the live organisms, '88 although high titres of serum antibody were attained.'97
Observations on man Blind volunteers with trachoma infection showed a 'greater tendency' to spontaneous cure of their eye infection after being inoculated with formolised, purified trachoma elementary bodies than a similar group given a placebo.192 Studies on normal volunteers showed that most vaccinated subjects were immune to challenge. However, as in the monkeys, those who developed disease had symptoms which were much more severe than in a natural infection, especially so if they had high titres of complement-fixing antibody in their sera. It was suggested that the method of immunisation played a vital role; large single doses of vaccine were found to favour a hypersensitivity reaction, while repeated small doses depressed hypersensitivity and provided protection.
Vaccine field trials Results of trachoma vaccine field trials point to the same major and somewhat disappointing conclusions. Firstly, although the incidence of trachoma was reduced in the immunised groups in some studies,'92 in others only the number of conjunctival inclusions found in infected individuals was reduced.'98 Further, while the effects of vaccination were noticeable in the population after six months, protection was very short-lived, varying from one year to 3.5 years after the second dose of vaccine.'92 199 200 In summary, resistance to reinfection by chlamydiae is dependent largely on local antibody production. This is stimulated best by natural infection but also by killed vaccines given locally. Parenteral vaccination has not been very successful and may result in more severe disease than experienced by unvaccinated controls. In human subjects, it is very unlikely that administration of a vaccine locally into the genital tract would be either a feasible or acceptable procedure. Recently, it has been suggested that resistance to chlamydial infection of the eye and genital tract may be induced by enteric vaccines.20' After oral administration of live guinea-pig inclusion conjunctivitis organisms, guinea-pigs were found to be partially protected against disease produced by live organisms introduced into the conjunctiva and the vagina. Application of antigens (non-chlamydial) to gastrointestinal mucosa has been shown to result in synthesis of secretory IgA at distant sites,20' and a similar phenomenon may account for the observations in the guinea-pig. If this approach were to be used in man, prevention of infection rather than just prevention of disease would be desirable. Furthermore, as for all human vaccines, at some stage it would seem necessary to administer enteric vaccines, killed and perhaps live, to human volunteers, followed by infectious challenge. This would appear to be a rather daunting proposition in what, in general, is a bleak outlook. We agree with Grayston and Wang202 that control of chlamydial genital infections through immunisation is not as promising an approach as education, diagnosis, treatment, and contact tracing.
Conclusions
The reasons for believing that certain serotypes of C. trachomatis cause genital-tract and associated diseases in men and women, and also disease in infants, have been discussed. A subjective quantitative summary of the evidence is presented in Table  10 . It is clear that for some conditions the evidence for a relationship with chlamydiae is poor or nonexistent, and further work is required to establish or refute whether the organisms are a cause. An analysis of the proportion of cases of each disease attributable to chlamydiae is also provided in Table 10 . In many instances the information is lacking or speculative guesses only can be made. Chlamydial culture techniques have become more sensitive and simple, but thought should be exercised in establishing a routine culture service. This would seem to be of no value in the management of male patients but in some women and infants it would be helpful in pointing to correct management and treatment. Apart from a few circumstances, serological investigations do not help in establishing a diagnosis. Surprisingly, perhaps, almost no information is available on the development or otherwise of immunity to human genital tract chlamydial infections. Studies on trachoma and experiments in animals suggest, however, that the outlook for successful human vaccination, even if acceptable, is bleak. Apart from filling in the gaps in Table 10 , further work should be directed towards determining (i) whether isolation techniques are optimal, (ii) whether detection of antibody in local secretions is helpful in diagnosis, (iii) the extent to which chlamydia culture-negative cases of disease might, in fact, be chlamydial, and (iv) the r6le of immunological mechanisms in pathogenesis.
